Replies to post #120860 on Biotech Values

[projectchris]

You can put me on record that lymphoseek will penetrate the sulfer colloid market with greater intensity than Cardinal is on record of stating. Cardinal is forecasting greater than 50% penetration within 18 months. I don't completely refute the small market niche bear case at least initially.

[DewDiligence]

Did you establish your NEOP short? The stock is off 30% in the past week.